Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Mackenzie

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Child: Care, Health and Development|November 10, 2011
Parenting children with neurodevelopmental disorders and/or behaviour problemsR E Garner, R G Arim, D E Kohen, et al.
Annals of Human Genetics|July 1, 1990
A cytogenetic and molecular reappraisal of a series of patients with Turner's syndromeP A Jacobs, P R Betts, A E Cockwell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyD Y Heng, M J Mackenzie, U N Vaishampayan, et al.
Critical Care (London, England)|March 5, 2013
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort studyJames S Krinsley, Moritoki Egi, Alex Kiss, et al.
British Journal of Cancer|April 3, 2014
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDCJ J Ko, T K Choueiri, B I Rini, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Child: Care, Health and Development|November 10, 2011
Parenting children with neurodevelopmental disorders and/or behaviour problemsR E Garner, R G Arim, D E Kohen, et al.
Annals of Human Genetics|July 1, 1990
A cytogenetic and molecular reappraisal of a series of patients with Turner's syndromeP A Jacobs, P R Betts, A E Cockwell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyD Y Heng, M J Mackenzie, U N Vaishampayan, et al.
Critical Care (London, England)|March 5, 2013
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort studyJames S Krinsley, Moritoki Egi, Alex Kiss, et al.
British Journal of Cancer|April 3, 2014
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDCJ J Ko, T K Choueiri, B I Rini, et al.
Pageof 2